|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.190 USD | +3.20% |
|
-9.98% | -2.40% |
| 06-29 | Galectin Therapeutics Inc.(NasdaqCM:GALT) added to Russell Small Cap Comp Growth Benchmark | CI |
| 06-29 | Galectin Therapeutics Inc.(NasdaqCM:GALT) added to Russell 2500 Growth Benchmark | CI |
Evolution of the Average Target: Galectin Therapeutics Inc.
Evolution of the Target Price: Galectin Therapeutics Inc.
Changes in Analyst Recommendations: Galectin Therapeutics Inc.
b003ab2563270674.T4cMpIJRlMaJkQBdYGVW5z9JEdmnQmcPx9N1AF-UuK8.f9hY4vMJxv7cqGILVjpkvk1-c7_-eyZMpqYXeQyk2e4W4GeTzhXX6__3UQ~586d54e6f253b1d5e8d0e519d955672e
| Consensus | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Objective/dr gap | ||
|---|---|---|---|---|---|---|
 | - | - | +170.94% | |||
| +14.2% | |||||
| +7.17% | |||||
| +10.48% | |||||
| +38.69% | |||||
| +46.5% | |||||
| +9.89% | |||||
| -16.13% | |||||
| +3% | |||||
| +7.81% | |||||
| Average | +29.25% | |||||
| Weighted average by Cap. | +16.39% |
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
4.060USD
Average target price
11.00USD
Spread / Average Target
+170.94%
High Price Target
11.00USD
Spread / Highest target
+170.94%
Low Price Target
11.00USD
Spread / Lowest Target
+170.94%
Analyst Consensus Detail
Consensus revision (last 18 months)
Analysts covering the company
| HC Wainwright |
SellBuy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
4.060USD
Average target price
11.00USD
Spread / Average Target
+170.94%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GALT Stock
- Consensus Galectin Therapeutics Inc.
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
